 |
 Video: What is a Stock Split?
|
|
|
| Immuron is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a class of polyclonal antibodies. Co.'s oral polyclonal antibodies provide delivery within the gastrointestinal track but do not cross into the bloodstream. Co. markets its commercial products Travelan® and Protectyn® in Australia, both products are listed medicines on the Australian Register for Therapeutic Goods. Co. also markets Travelan® in Canada where it is licensed as a natural health product indicated to reduce the risk of travelers' diarrhea, and market Travelan® as a dietary supplement for digestive tract protection. According to our Immuron stock split history records, Immuron has had 0 splits. | |
|
Immuron (IMRN) has 0 splits in our Immuron stock split history database.
Looking at the Immuron stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Immuron shares, starting with a $10,000 purchase of IMRN, presented on a split-history-adjusted basis factoring in the complete Immuron stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/12/2017 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$8.70 |
|
| End price/share: |
$2.41 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-72.30% |
|
| Average Annual Total Return: |
-17.08% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,771.08 |
|
| Years: |
6.85 |
|
|
|
|
|
